Prof. Dr. Hüseyin Cem Önal Özgeçmiş Sayfası

1

Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study, Journal of Pseudo-Differential Operators and Applications, 31(3), 2023 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Oymak E, Yazici G, Akagunduz Oo, Cetinayak O

2

Contralateral breast radiation doses in breast cancer patients treated with helical tomotherapy, Medical Dosimetry, 48(1), 2023 SCI / SCI EXPANDED

Ezgi Oymak 1, Prof. Dr. Erkan Topkan, Recep Bozca 2, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

3

Comparison of helical and TomoDirect techniques with simultaneous integrated boost in early breast cancer patients, Reports of Practical Oncology and Radiotherapy, 4(0), 2023 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Bozca R, Oymak E, Prof. Dr. Ozan Cem Güler

4

Prostat Kanseri Radyoterapisinde PSMA-PET Güvenilirliği ve Kısıtlılığı, nükleer tıp seminerleri, 1(0), 2023 SSCI

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

5

Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. In regard to Rajwa et al, European Urology Oncology, 2023(0), 2023 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler

6

The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [68Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy, Eur J Nucl Med Mol Imaging, 50(0), 2023 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Ezgi Oymak, Prof. Dr. Mehmet Reyhan

7

The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients, RADIOTHERAPY AND ONCOLOGY, 184(0), 2023 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Erbay G, Oymak E, Prof. Dr. Ozan Cem Güler

8

Multi-institutional study on the role of post-operative radiotherapy in elderly patients with endometrial cancer, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 33(5), 2023 SCI / SCI EXPANDED

Yavas G, Prof. Dr. Ozan Cem Güler, Gultekin M, Oymak E, Yuce Sari S

9

Re: Francolini et al.: Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis., CLINICAL ONCOLOGY, 34(1), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

10

Re: Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease., CLINICAL ONCOLOGY, 34(4), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler

11

Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomes, the journal of obstetrics and gynecological researh, 48(7), 2022 SCI / SCI EXPANDED

Yuce Sari S, Prof. Dr. Ozan Cem Güler, Oymak E, Gultekin M, Yigit E

12

Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study, STRAHLENTHERAPIE UND ONKOLOGIE, 198(10), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Hurmuz P, Yavas G, Tilki B

13

Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study, STRAHLENTHERAPIE UND ONKOLOGIE, 199(5), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E, Prof. Dr. Ozan Cem Güler, Tilki B, Yavas G

14

The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma, Clinical & Translational Oncology, 24(8), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Hurmuz P, Prof. Dr. Ozan Cem Güler, Yavas G, Tilki B

15

Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy., Journal of Pseudo-Differential Operators and Applications, 198(3), 2022 SCI / SCI EXPANDED

Oymak E, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

16

The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 42(6), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Gultekin M, Yavas G, Oymak E, Yuce Sari S

17

There is no doubt about the winner of the lion?rabbit fight, PROSTATE, 82(12), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler

18

Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002, European Urology Oncology, 5(4), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

19

The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy, RADIOTHERAPY AND ONCOLOGY, 173(0), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Prof. Dr. Ozan Cem Güler, Oymak E

20

Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial, EUROPEAN JOURNAL OF CANCER, 167(0), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

21

Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma, Journal of Pseudo-Differential Operators and Applications, 107(2), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Oymak E, Hurmuz P, Yavas G, Tilki B.

22

Prognostic significance of albumin and globulin levels in cervical cancer patients treated with chemoradiotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 33(1), 2022 SCI / SCI EXPANDED

Oymak E, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

23

Longer treatment time and lower radiation doses?an alternative for Graves? ophthalmopathy treatment, STRAHLENTHERAPIE UND ONKOLOGIE, 198(7), 2022 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler

24

Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948-54, European Urology Oncology, 5(4), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, İsci O., Prof. Dr. Hüseyin Cem Önal

25

Dosimetric Comparison of Volumetric Arc Therapy Methods for Stereotactic Body Radiotherapy in Liver Metastasis, Turkish journal of oncology, 37(4), 2022 SSCI

Oymak E, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

26

Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients with Pathologic Negative Nodes after Neoadjuvant Chemotherapy. In regard to Schlafstein et al., Clinical Breast Cancer, 22(3), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

27

Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis. In regard to De Virgilio et al, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148(9), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

28

Validating Modern NRG Oncology Pelvic Nodal and Groupe Francophone de Radiothérapie Urologique Prostate Bed Contouring Guidelines for Post-prostatectomy Salvage Radiation: A Secondary Analysis of the LOCATE Trial. In Regard to Harmon et al., INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 112(2), 2022 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

29

Long-term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.: in regard to Lin et al. , CLINICAL ONCOLOGY, 33(0), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler

30

Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al., MEDICAL ONCOLOGY, 38(7), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E, Prof. Dr. Ozan Cem Güler

31

Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy, ACTA ONCOLOGICA, 60(9), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Yuce Sari S, Yavas G, Oymak E, Duru Birgi S

32

Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 31(2), 2021 SCI / SCI EXPANDED

Gultekin M, Beduk Esen Cs, Balci B, Alanyali S, Akkus Yildirim B

33

Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 11(0), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Oymak E, Prof. Dr. Ozan Cem Güler, Tilki B

34

Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients, PROSTATE, 108(3), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Oymak E, Prof. Dr. Ozan Cem Güler, Hurmuz P

35

The clinical outcomes of ovarian cancer in patients with brain metastasis, EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 42(5), 2021 SCI / SCI EXPANDED

Seda Yuksel Simsek1, Prof. Dr. Ozan Cem Güler, Gülşen Doğan Durdag1, Sezin Yüce Sari3, Melis Gultekin3

36

NRG oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer: In Regard to Hall et al, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 110(2), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Oymak E., Prof. Dr. Ozan Cem Güler

37

The clinical outcomes of ovarian cancer in patients with brain metatstasis, ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 0(0), 2021 SCI / SCI EXPANDED

Seda Yüksel Şimşek, Prof. Dr. Ozan Cem Güler, Doç. Dr. Gülşen Doğan Durdağ, Sezin Yüce Sarı, Murat Gültekin

38

Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 81(9), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Kose F, Ozyigit G, Aksoy S, Oymak E

39

Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapy, Future Oncology, 17(25), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Sari Sy, Yavas G, Prof. Dr. Ozan Cem Güler, Yigit E

40

Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate CancerIn Regard to Deek et al. , INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 110(5), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Oymak E

41

Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated with Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study, CLINICAL NUCLEAR MEDICINE, 46(6), 2021 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Akgun Z, Atalar B, İgdem S

42

Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 40(7), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Yuce Sari S, Yildirim Ba, Gultekin M, Prof. Dr. Ozan Cem Güler

43

Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse, LEUKEMIA RESEARCH, 41(6), 2020 SCI / SCI EXPANDED

50. Kose F, Alemdaroglu S, Besen Aa, Prof. Dr. Ozan Cem Güler, Mertsoylu H

44

Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 30(6), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Gultekin M, Oymak E, Prof. Dr. Ozan Cem Güler, Yilmaz Mt

45

Half-dose bevacizumab experience in relapsed ovarian cancer patients in Turkey due to formal regulations: similar effectiveness with lower rate of hypertension, Journal of BUON, 25(4), 2020 SCI / SCI EXPANDED

Fatih Kose 1, Songul Alemdaroglu, Huseyin Mertsoylu, Ali Ayberk Besen, Prof. Dr. Ozan Cem Güler

46

The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer, BREAST, 54(0), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Alper Findikcioğlu, Prof. Dr. Ozan Cem Güler, Prof. Dr. Mehmet Reyhan

47

Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy, BREAST, 80(4), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Yildirim Ba

48

Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients, Radiologia Medica, 125(8), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Bozca R, Dolek Y, Prof. Dr. Ozan Cem Güler, Arslan G.

49

Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, RADIOTHERAPY AND ONCOLOGY, 151(0), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Prof. Dr. Ozan Cem Güler, Hurmuz P, Torun N

50

The effect of androgen deprivation therapy on Ga-68-PSMA tracer uptake in non-metastatic prostate cancer patients, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47(3), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ali Fuat Yapar

51

National, Observational, Multicentric Retrospective Study to Understand Treatment Patterns, Patient Journey and Characteristics with Stage III Non-Small Cell Lung Cancer Patients in Turkey: Stone Trial, International Journal of Hematology and Oncology, 108(3), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Demiral An, Atalar B, Prof. Dr. Ozan Cem Güler, Yalman D

52

Retrospective correlation of (68)ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy, ANNALS OF NUCLEAR MEDICINE, 34(6), 2020 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Torun N, Oymak E, Prof. Dr. Ozan Cem Güler, Reyhan M

53

Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002), STRAHLENTHERAPIE UND ONKOLOGIE, 196(11), 2020 SCI / SCI EXPANDED

Hurmuz P, Prof. Dr. Hüseyin Cem Önal, Ozyigit G, İgdem S, Atalar B

54

Concurrent versus sandwich treatment in adjuvant treatment in high risk operated gastric cancer: A single center experience, Journal of BUON, 25(5), 2020 SCI / SCI EXPANDED

Sezer A, Akkus B, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Sumbul At.

55

Local Control and Vertebral Compression Fractures Following Stereotactic Body Radiotherapy for Spine Metastases, Journal of Bone Oncology, 24(15), 2019 SCI / SCI EXPANDED

Doç. Dr. Yurday Özdemir, Doç. Dr. Neşe Torun, Prof. Dr. Ozan Cem Güler, Berna Akkuş, Ali Ayberk Beşen

56

Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide, INDIAN JOURNAL OF CANCER, 56(1), 2019 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan

57

Validation of the ESMO-ESGO-ESTRO Consensus Conference Risk Grouping in Turkish Endometrial Cancer Patients Treated with Comprehensive Surgical Staging, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), 2019 SCI / SCI EXPANDED

Gultekin M, Prof. Dr. Ozan Cem Güler, Guler Oc, Yuce Sari S, Akkus Yildirim B

58

The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 39(5), 2019 SCI / SCI EXPANDED

Yıldırım Ba, Prof. Dr. Ozan Cem Güler, Prof. Dr. Fatih Köse, Prof. Dr. Hüseyin Cem Önal

59

Prognostic values of ADCmean and SUVmax of the primary tumor in cervical cancer patients treated with definitive chemoradiotherapy., JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 0(0), 2019 SCI / SCI EXPANDED

56. Akkus Yildirim B, Prof. Dr. Hüseyin Cem Önal, Erbay G, Prof. Dr. Ozan Cem Güler, Karadeli E

60

The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate., Future Oncology, 37(7), 2019 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Sedef Am, Kose F, Oymak E, Prof. Dr. Ozan Cem Güler

61

Prognostic Value of Metabolic Response Measured by FDG-PET-CT in Patients with Breast Cancer Liver Metastasis Treated with Stereotactic Body Radiotherapy, Current Medical Imaging Reviews, 33(3), 2019 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal

62

Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients, CLINICAL NUCLEAR MEDICINE, 44(9), 2019 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Torun N, Akyol F, Prof. Dr. Ozan Cem Güler, Hurmuz P

63

A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma, Journal of Gynecologic Oncology, 30(3), 2019 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Sari Sy, Yildirim Ba, Yavas G, Gultekin M

64

Treatment outcomes of endometrial cancer patients with paraaortic lymph node metastasis: a multi-institutional analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 29(1), 2019 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Akkus Yildirim B, Yuce Sari S, Yavas G, Gultekin M

65

Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate, STRAHLENTHERAPIE UND ONKOLOGIE, 195(10), 2019 SCI / SCI EXPANDED

66. Yildirim Ba, Prof. Dr. Hüseyin Cem Önal, Kose F, Oymak E, Sedef Am

66

Radiotherapy After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction, Clinical Breast Cancer, 19(5), 2019 SCI / SCI EXPANDED

Yuce Sari S, Prof. Dr. Ozan Cem Güler, Gultekin M, Akkus Yildirim B, Prof. Dr. Hüseyin Cem Önal

67

Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery, IN VIVO, 33(6), 2019 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Efe E, Prof. Dr. Ozan Cem Güler, Yıldırım Ba

68

Dosimetric comparison of vaginal vault brachytherapy vs applicator-guided stereotactic body radiotherapy with volumetric modulated arc therapy and helical tomotherapy for endometrium cancer patients, Medical Dosimetry, 44(4), 2019 SCI / SCI EXPANDED

Yıldırım Ba, Dolek Y, Prof. Dr. Ozan Cem Güler, Arslan G, Prof. Dr. Hüseyin Cem Önal

69

Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy, STRAHLENTHERAPIE UND ONKOLOGIE, 195(10), 2019 SCI / SCI EXPANDED

Ozyigit G, Prof. Dr. Hüseyin Cem Önal, Igdem S, Arican Alicikus Z, Iribas A

70

The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients, Clinical & Translational Oncology, 20(4), 2018 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Benedikt Engels, Prof. Dr. Hüseyin Cem Önal, Evaraert H, Van Den Begin R

71

Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy, NUCLEAR MEDICINE COMMUNICATIONS, 39(6), 2018 SCI / SCI EXPANDED

Yıldırım Ba, Doç. Dr. Neşe Torun, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

72

Mide Kanserinde Definitif Radyoterapi. Üst Gastrointestinal Kanserlerde Radyoterapi. , Türkiye Klinikleri, 1(0), 2018 SSCI

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

73

Concurrent cisplatin and radiotherapy versus cetuximab and radiotherapy, an unsolved problem, ANNALS OF ONCOLOGY, 29(3), 2018 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Ozyar E

74

Responding to Veiga et al. 'Long term radiological features of radiation-induced lung damage', RADIOTHERAPY AND ONCOLOGY, 129(3), 2018 SCI / SCI EXPANDED

Oymak E, Yıldırım Ba, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

75

The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 28(8), 2018 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Yıldırım Ba., Prof. Dr. Ozan Cem Güler, Mertsoylu H

76

Lokalize Prostat Kanserinde Radyoterapi, Türkiye Klinikleri, 0(0), 2017 SSCI

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal

77

Pretreatment metabolic tumor volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy., JOURNAL OF MARINE RESEARCH, 0(0), 2017 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal

78

Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images, ACTA RADIOLOGICA, 58(4), 2017 SCI / SCI EXPANDED

Prof. Dr. Gürcan Erbay, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Elif Karadeli, Prof. Dr. Ozan Cem Güler, Arica S

79

Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient?, Oncology Research and Treatment, 40(9), 2017 SCI / SCI EXPANDED

Yuce Sari S, Prof. Dr. Ozan Cem Güler, Gultekin M, Prof. Dr. Hüseyin Cem Önal, Yildiz F.

80

Outcomes of aggressive treatment in esophageal cancer patients with synchronous solitary brain metastasis, molecular and clinical oncology, 7(1), 2017 SSCI

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Yıldırım Ba

81

The role of delineation education programs for improving interobserver variability in target volume delineation in gastric cancer, BRITISH JOURNAL OF RADIOLOGY, 90(1073), 2017 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Cengiz M, Prof. Dr. Ozan Cem Güler, Dolek Y, Ozkok S

82

Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 27(7), 2017 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Sezin Yüce Sarı, Sumerya Duru Birgi, Melis Bahadır, Ferah Yıldız

83

Prognostic value of metabolic response measured by F-18-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy, NUCLEAR MEDICINE COMMUNICATIONS, 37(12), 2016 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Neşe Torun, Prof. Dr. Ozan Cem Güler, Yıldırım Ba

84

Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF MAGNETIC RESONANCE IMAGING, 44(4), 2016 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Prof. Dr. Ozan Cem Güler

85

Metachronous Prostate Metastasis of Renal Cell Carcinoma: Case Report and Review of the Literature, Clinical Genitourinary Cancer, 14(2), 2016 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Nebil Bal, Prof. Dr. Hüseyin Cem Önal

86

Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 26(6), 2016 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Yıldırım Ba

87

Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature, WIENER KLINISCHE WOCHENSCHRIFT, 128(7), 2016 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Müh. Güngör Arslan

88

Prognostic value of F-18-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy, GYNECOLOGIC ONCOLOGY, 137(1), 2015 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ali Fuat Yapar

89

Correlation of Clinical Risk Factors with Diffusion-Weighted Magnetic Resonance Images in Prostate Cancer Patients Treated with Definitive Radiotherapy, UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi, 25(2), 2015 SCI / SCI EXPANDED

Erbay, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Prof. Dr. Elif Karadeli, Koc Z

90

The impact of air pockets around the vaginal cylinder on vaginal vault brachytherapy., Journal of Cancer Research and Therapeutics, 0(0), 2015 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Dolek Y

91

Metastatik Evre ve Lokal Nükslerde Radyoterapi, Türkiye Klinikleri, 0(0), 2015 SSCI

Prof. Dr. Ozan Cem Güler, Doç. Dr. Yurday Özdemir, Prof. Dr. Hüseyin Cem Önal

92

Prostate Mucinous Carcinoma Treated With Definitive Radiotherapy and Hormonal Therapy: Case Report and Review of the Literature, Clinical Genitourinary Cancer, 12(2), 2014 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Prof. Dr. Nebil Bal

93

Uterine Perforation During 3-Dimensional Image-Guided Brachytherapy in Patients With Cervical Cancer Baskent University Experience, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 24(2), 2014 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Ozan Cem Güler, Dolek Y, Prof. Dr. Gürcan Erbay

94

Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 41(7), 2014 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ozan Cem Güler, Prof. Dr. Ali Fuat Yapar

95

Definitive Chemoradiation Therapy Following Surgical Resection or Radiosurgery Plus Whole-Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients With Synchronous Solitary Brain Metastasis: A Curative Approach, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 88(4), 2014 SCI / SCI EXPANDED

Parlak C, Mertsoylu H, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan

96

Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy, BRITISH JOURNAL OF RADIOLOGY, 87(1034), 2014 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Sonmez S, Erbay G, Prof. Dr. Ozan Cem Güler, Arslan G

97

Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer, Journal of Contemporary Brachytherapy, 6(4), 2014 SCI / SCI EXPANDED

Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Acibuci İ

98

Comparison of computed tomography- and positron emission tomography-based radiotherapy planning in cholangiocarcinoma, Oncologie, 36(9), 2013 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan, Prof. Dr. Ali Fuat Yapar, S Topuk, A Yavuz

99

PROGNOSTIC VALUE OF PRETREATMENT FDG UPTAKE IN CERVICAL CANCER PATIENTS TREATED WITH DEFINITIVE CHEMORADIOTHERAPY, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23(8), 2013 SCI / SCI EXPANDED

Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Mehmet Reyhan, Parlak C, Prof. Dr. Ozan Cem Güler, Oymak E

100

Plasma citrulline levels predict intestinal toxicity in patients treated with pelvic radiotherapy., ACTA ONCOLOGICA, 50(8), 2011 SCI / SCI EXPANDED

Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, A Kötek, Uzm.Dr. Birsel Ünal, Prof. Dr. Erkan Topkan

101

Protective effects of melatonin and octreotide against radiation-induced intestinal injury., DIGESTIVE DISEASES AND SCIENCES, 56(2), 2011 SCI / SCI EXPANDED

Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Fazilet Kayaselçuk, Prof. Dr. Erkan Topkan, D Bacanlı

102

Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis, Radiation Oncology, 11(0), 2009 SCI / SCI EXPANDED

Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan, A Yavuz, E Efe

103

The effect of concurrent androgen deprivation and 3D conformal radiotherapy on prostate volume and clinical organ doses during the course of treatment in prostate cancer, BRITISH JOURNAL OF RADIOLOGY, 82(0), 2009 SCI / SCI EXPANDED

Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, A Yavuz, G Arslan, Prof. Dr. Erkan Topkan

104

Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses., J Exp Clin Cancer Res, 28(0), 2009 SCI / SCI EXPANDED

Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, A Yavuz, G Arslan, Prof. Dr. Erkan Topkan

105

Managing liver metastases with conformal radiation therapy, J SUPPORT ONCOL, 1(0), 2008 SCI / SCI EXPANDED

Prof. Dr. Melek Nur Yavuz, Prof. Dr. Erkan Topkan, Prof. Dr. Hüseyin Cem Önal

Yayın ve Akademik Faaliyet Özeti